Celgene Receives Positive CHMP Opinion for ABRAXANE® for First-Line Treatment of Patients with Non-Small Cell Lung Cancer

… . Non-small cell lung cancer (NSCLC) is the most common form of lung cancer, accounting … for the treatment of lung cancer. “Progress in lung cancer will come first from … advanced or metastatic non-small cell lung cancer (NSCLC), in combination with carboplatin …